SBIR/STTR Reauthorization Strengthens Early Stage Medtech Innovation (medmarc.com)
The recent reauthorization of the SBIR and STTR programs boosts funding for small medtech companies, fostering innovation essential for patient care.
The SBIR/STTR programs have been reauthorized, ensuring continued non-dilutive funding for small #MedTech innovators. This renewed support helps bridge financing gaps and advances transformative technologies for patient care. medmarc.com/life-science...
